Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverEMPG
HealthcareNCMUSD

Empro Group Inc.

$0012345678900123456789.00123456789001234567890.0%
52w low (est.) $13.71$22.05 52w high (est.)
Market data · updated 7m ago
Market data
Market cap
USD143.05M
52w range
USD3.00 - USD18.14
Beta
1.00
Sector
Healthcare
Data quality
88/100
Valuation
P/E ratio
192.9x
DCF fair value
USD6.94
Margin of safety
-60.0%
Quality & efficiency
Moat score
67/100
Return on equity
66.3%
Profit margin
13.7%
Debt / equity
1.00
Growth & analysts
Revenue growth
+141.6%
Run the 10-point checklist before you buy How these numbers are made

About Empro Group Inc.

Empro Group Inc., through its subsidiary, sells healthcare and beauty products in Malaysia and internationally. The company offers eyebrow pencils, skincare and antibacterial moisturizing mist products, surgical face masks, nitrile gloves, test kits, lips natural recovery cream, and black diamond eyeliners under the Empro, Premio, SpaceLift, and Mios brands. It sells its products through retails stores and online retail. The company was founded in 2004 and is based in Shah Alam, Malaysia.

Valuation

ValueGrowthProfitHealthIncome55QUALITY
Overall Rating
35
Reduce
Reduce

Derived from filed metrics · High confidence (88% of the inputs available)

Moat Score67
DCF Intrinsic Value
USD6.94-60.0% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD143.05M
P/E Ratio
192.9
Dividend Yield
0.00%
Revenue Growth
+141.6%
Profit Margin
13.7%
ROE
66.3%
Debt / Equity
1.00
Beta
1.00
High GrowthMomentum
vs Healthcare sector:P/E 193 vs 28 Moat 67 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · EMPG